David Bennett to Heterozygote
This is a "connection" page, showing publications David Bennett has written about Heterozygote.
Connection Strength
0.478
-
EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE e4 ON ALZHEIMER'S DISEASE RISK IN HUMANS. Alzheimers Dement. 2020 12; 16(Suppl 2).
Score: 0.177
-
APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
Score: 0.105
-
Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
Score: 0.045
-
APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
Score: 0.038
-
APOE e4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline. Neurology. 2016 05 31; 86(22):2063-70.
Score: 0.032
-
APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
Score: 0.031
-
The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
Score: 0.027
-
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 2011 Feb; 7(2):e1001308.
Score: 0.022